TheMedicalSoft: what changed
TheMedicalSoft
Largest movements
- Intangible fixed assets -€22,878
down €22,878 (-15.2%), from €150,081 to €127,204
- Cash -€3,602
down €3,602 (-71.1%), from €5,064 to €1,462
mainly Net result for the year (-€29,669)
- Financial fixed assets -€2,500
no longer reported in 2025 (was €2,500)
- Profit (loss) carried forward -€29,669
down €29,669 (-20.5%), from -€144,506 to -€174,175
- Gross operating margin -€1,235
down €1,235 (-52.2%), from -€2,368 to -€3,603
- Other operating charges +€174
up €174 (+45.3%), from €384 to €559
- Financial charges -€159
down €159 (-55.0%), from €289 to €130
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €158,131 | €129,009 | -€29,122 | -18.4% |
| Fixed assets | 21/28 | €152,581 | €127,204 | -€25,378 | -16.6% |
| Intangible fixed assets | 21 | €150,081 | €127,204 | -€22,878 | -15.2% |
| Financial fixed assets | 28 | €2,500 | - | -€2,500 | |
| Current assets | 29/58 | €5,550 | €1,805 | -€3,744 | -67.5% |
| Amounts receivable within one year | 40/41 | €485 | €343 | -€142 | -29.3% |
| Trade receivables | 40 | €305 | €305 | = | 0.0% |
| Other amounts receivable | 41 | €180 | €38 | -€142 | -78.8% |
| Cash at bank and in hand | 54/58 | €5,064 | €1,462 | -€3,602 | -71.1% |
| Total equity and liabilities | 10/49 | €158,131 | €129,009 | -€29,122 | -18.4% |
| Equity | 10/15 | €157,951 | €128,282 | -€29,669 | -18.8% |
| Contributions | 10/11 | €302,457 | €302,457 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€144,506 | -€174,175 | -€29,669 | -20.5% |
| Amounts payable | 17/49 | €180 | €727 | +€547 | +304% |
| Amounts payable within one year | 42/48 | €180 | €727 | +€547 | +304% |
| Trade debts | 44 | - | €547 | +€547 | |
| Suppliers | 440/4 | - | €547 | +€547 | |
| Other amounts payable | 47/48 | €180 | €180 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,878 | €22,878 | = | 0.0% |
| Other operating charges | 640/8 | €384 | €559 | +€174 | +45.3% |
| Non-recurring operating charges | 66A | - | €2,500 | +€2,500 | |
| Gross operating margin | 9900 | -€2,368 | -€3,603 | -€1,235 | -52.2% |
| Operating profit (loss) | 9901 | -€25,630 | -€29,539 | -€3,909 | -15.3% |
| Financial income | 75/76B | €2 | - | -€2 | |
| Recurring financial income | 75 | €2 | - | -€2 | |
| Financial charges | 65/66B | €289 | €130 | -€159 | -55.0% |
| Recurring financial charges | 65 | €289 | €130 | -€159 | -55.0% |
| Profit (loss) for the period before taxes | 9903 | -€25,916 | -€29,669 | -€3,753 | -14.5% |
| Profit (loss) for the period | 9904 | -€25,916 | -€29,669 | -€3,753 | -14.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€25,916 | -€29,669 | -€3,753 | -14.5% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 October 2024 and 31 October 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.